TaiMed Biologics Inc. (TPEX: 4147)

TaiMed Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21,759	20,746	17,843	17,813	21,212	24,991
Market Cap Growth	-2.58%	16.27%	0.17%	-16.02%	-15.12%	-39.85%
Enterprise Value	20,113	20,859	17,860	17,487	20,408	23,356
Last Close Price	79.70	80.83	69.69	69.59	82.90	97.68
Forward PE	-	282.76	-	-	87.60	-
PS Ratio	33.19	42.19	31.69	43.09	29.36	35.47
PB Ratio	5.19	8.08	6.57	6.06	6.21	6.97
P/TBV Ratio	6.07	10.69	8.96	8.40	8.57	8.78
EV/Sales Ratio	32.30	42.42	31.72	42.30	28.25	33.15
EV/EBITDA Ratio	-	-	-	-	8869.02	-
Debt / Equity Ratio	0.13	0.29	0.28	0.19	0.17	0.01
Debt / EBITDA Ratio	-	-	-	-	130.59	-
Asset Turnover	0.13	0.12	0.13	0.08	0.15	0.15
Inventory Turnover	0.28	0.20	0.27	0.27	0.29	0.76
Quick Ratio	3.20	2.31	2.32	5.12	3.23	3.51
Current Ratio	5.66	5.96	6.56	10.37	6.02	5.74
Return on Equity (ROE)	-4.17%	-7.38%	-9.52%	-14.82%	-5.24%	-15.09%
Return on Assets (ROA)	-1.93%	-2.60%	-2.75%	-6.20%	-1.67%	-5.12%
Return on Capital (ROIC)	-2.32%	-3.06%	-3.43%	-8.11%	-2.18%	-6.33%
Earnings Yield	-0.69%	-0.94%	-1.51%	-2.64%	-0.86%	-2.32%
FCF Yield	0.68%	-0.15%	-3.41%	-1.24%	-1.20%	-3.11%
Buyback Yield / Dilution	-2.30%	-0.18%	-0.04%	-0.03%	-0.07%	-0.52%
Total Shareholder Return	-2.30%	-0.18%	-0.04%	-0.03%	-0.07%	-0.52%

Source: S&P Capital IQ. Standard template. Financial Sources.